OBJECTIVES: Bipolar disorder and schizophrenia share common pathophysiological processes and may have similar perceptual abnormalities. Mismatch negativity (MMN) and P3a - event-related potentials associated with auditory preattentional processing - have been extensively studied in schizophrenia, but rarely in bipolar disorder. Furthermore, MMN and P3a have not been examined between diagnostic subgroups of patients with bipolar disorder. We evaluated MMN and P3a in patients with bipolar disorder compared to patients with schizophrenia and healthy controls. METHODS: MMN and P3a were assessed in 52 bipolar disorder patients, 30 schizophrenia patients, and 27 healthy control subjects during a duration-deviant auditory oddball paradigm. RESULTS: Significant MMN and P3a amplitude reductions were present in patients with bipolar disorder and schizophrenia relative to controls. The MMN reduction was more prominent in patients with schizophrenia than bipolar disorder, at a trend level. P3a did not differ significantly between patient groups. There were no MMN or P3a differences between patients with bipolar I (n = 34) and bipolar II (n = 18) disorder. Patients with bipolar I disorder failed to show lateralized MMN, in contrast to the other groups. No MMN or P3a differences were found between patients with bipolar disorder taking (n = 12) and not taking (n = 40) lithium, as well as between those taking (n = 30) and not taking (n = 22) antipsychotic medications. CONCLUSIONS: Patients with bipolar disorder showed deficits in preattentive auditory processing, including MMN deficits that are less severe and P3a deficits that are slightly more pronounced, than those seen in schizophrenia.
OBJECTIVES:Bipolar disorder and schizophrenia share common pathophysiological processes and may have similar perceptual abnormalities. Mismatch negativity (MMN) and P3a - event-related potentials associated with auditory preattentional processing - have been extensively studied in schizophrenia, but rarely in bipolar disorder. Furthermore, MMN and P3a have not been examined between diagnostic subgroups of patients with bipolar disorder. We evaluated MMN and P3a in patients with bipolar disorder compared to patients with schizophrenia and healthy controls. METHODS:MMN and P3a were assessed in 52 bipolar disorderpatients, 30 schizophreniapatients, and 27 healthy control subjects during a duration-deviant auditory oddball paradigm. RESULTS: Significant MMN and P3a amplitude reductions were present in patients with bipolar disorder and schizophrenia relative to controls. The MMN reduction was more prominent in patients with schizophrenia than bipolar disorder, at a trend level. P3a did not differ significantly between patient groups. There were no MMN or P3a differences between patients with bipolar I (n = 34) and bipolar II (n = 18) disorder. Patients with bipolar I disorder failed to show lateralized MMN, in contrast to the other groups. No MMN or P3a differences were found between patients with bipolar disorder taking (n = 12) and not taking (n = 40) lithium, as well as between those taking (n = 30) and not taking (n = 22) antipsychotic medications. CONCLUSIONS:Patients with bipolar disorder showed deficits in preattentive auditory processing, including MMN deficits that are less severe and P3a deficits that are slightly more pronounced, than those seen in schizophrenia.
Authors: Klaus Mathiak; Alexander Rapp; Tilo T J Kircher; Wolfgang Grodd; Ingo Hertrich; Nikolaus Weiskopf; Werner Lutzenberger; Hermann Ackermann Journal: Hum Brain Mapp Date: 2002-07 Impact factor: 5.038
Authors: Robert E McCullumsmith; Lars V Kristiansen; Monica Beneyto; Elizabeth Scarr; Brian Dean; James H Meador-Woodruff Journal: Brain Res Date: 2006-11-17 Impact factor: 3.252
Authors: Daniel Umbricht; Daniel Javitt; Gerald Novak; John Bates; Simcha Pollack; Jeffrey Lieberman; John Kane Journal: Int J Neuropsychopharmacol Date: 1999-12 Impact factor: 5.176
Authors: Daniel S G Umbricht; John A Bates; Jeffrey A Lieberman; John M Kane; Daniel C Javitt Journal: Biol Psychiatry Date: 2006-02-21 Impact factor: 13.382
Authors: Michael Avissar; Shanghong Xie; Blair Vail; Javier Lopez-Calderon; Yuanjia Wang; Daniel C Javitt Journal: Schizophr Res Date: 2017-07-11 Impact factor: 4.939
Authors: Kate M Chitty; Jim Lagopoulos; Manreena Kaur; Ian B Hickie; Daniel F Hermens Journal: Int J Neuropsychopharmacol Date: 2015-01-20 Impact factor: 5.176
Authors: Mei-Hua Hall; Jordan W Smoller; Nancy R Cook; Katja Schulze; Phil Hyoun Lee; Grantley Taylor; Elvira Bramon; Michael J Coleman; Robin M Murray; Dean F Salisbury; Deborah L Levy Journal: Psychiatry Res Date: 2012-08-24 Impact factor: 3.222
Authors: Manreena Kaur; Jim Lagopoulos; Philip B Ward; Tamara L Watson; Sharon L Naismith; Ian B Hickie; Daniel F Hermens Journal: PLoS One Date: 2012-12-14 Impact factor: 3.240